---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-026578"
form_type: "8-K"
ticker: "IOVA"
cik: "0001425205"
company_name: "IOVANCE BIOTHERAPEUTICS, INC."
filed_at: "2024-02-22T23:59:59+00:00"
generated_at: "2026-06-05T18:58:06.645457+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Iovance closes $197.1M public offering of 23M shares at $9.15/share

## Summary
- Closed sale of 23,014,000 shares at $9.15 per share in underwritten offering.
- Net proceeds expected to be approximately $197.1M after discounts and expenses.
- Offering previously disclosed; closing occurred on February 22, 2024.

## SEC filing metadata
- accession: 0001104659-24-026578
- form_type: 8-K
- ticker: IOVA
- cik: 0001425205
- company_name: IOVANCE BIOTHERAPEUTICS, INC.
- filed_at: 2024-02-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425205/000110465924026578/0001104659-24-026578-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425205/000110465924026578/tm246821d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-026578
- JSON: https://secwatch.observer/filing/0001104659-24-026578.json
- Plain text: https://secwatch.observer/filing/0001104659-24-026578.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.